Nilai perusahaan marang bathi resik MeiraGTx Holdings (MGTX)

Simbol lan logo merek MeiraGTx Corp (MGTX)

MeiraGTx Holdings plc (MGTX) is developing versatile gene therapy systems in ophthalmology and neurology, mitigating risks through in-house manufacturing. Growth is driven by collaboration with J&J and gene expression control methods. An active R&D pipeline based on the AAV platform is preparing breakthrough solutions for retinal treatment. The company's price-to-earnings ratio confirms these data, where the parameter value equals 10.70.

MeiraGTx Holdings plc (MGTX): Pangali P/E saka 04.07.2022 nganti 18.11.2026

Rincian analitis perusahaan MeiraGTx (MGTX)

- nilai pasar lan prakiraan target analis:
Analisis umum perusahaan:MeiraGTx - MGTX
Produk dadi meiragtx.com

The integration of AI into molecular modeling and the robotization of drug synthesis at MeiraGTx Holdings plc (MGTX) are accelerating therapy development, although reliance on costly clinical trials impacts net income. By analyzing the company's rolling P/E, an investor assesses the market value of one dollar of earnings, which helps determine whether the asset's current price is justified relative to its actual ability to generate cash flow.

Pesaing wigati

tempus.com - Kapitalisasi marang bathi resik|Pangali P/E QGEN|Periode bali modal bisnis Isis Pharmaceuticals|Pangali P/E RGEN (repligen.com)|Rasio rega pasar marang bathi resik RNA (Avidity Biosciences, Inc.)|CRSP - Rasio rega marang bathi|Nilai perusahaan marang bathi resik WGS (GeneDx)|RARE: Pangali P/E|Beam Therapeutics Corp - Nilai perusahaan marang bathi resik|Koefisien rega marang bathi SRPT|twistbioscience.com (TWST) - Periode bali modal bisnis|Pangali P/E TXG|NTLA (Intellia) - Nilai perusahaan marang bathi resik|Rasio rega marang bathi Stoke STOK|BioLife (BLFS) - Kapitalisasi marang bathi|wavelifesciences.com - Pangali P/E|Kapitalisasi marang bathi resik MAZE|SION: Pangali P/E|PRME - Periode bali modal bisnis|Koefisien rega marang bathi TSHA|QURE - Rasio kapitalisasi marang bathi resik|Koefisien rega marang bathi RGNX (regenxbio.com)|Solid Biosciences Inc. - Pangali rega marang bathi|Rasio rega marang bathi Ocugen Corp OCGN|Pacific Biosciences of California, Inc. (PACB) - Kapitalisasi marang bathi|BNTC - Rasio rega marang bathi|Design Pharma - Rasio rega pasar marang bathi resik|RCKT (Rocket Pharmaceuticals Inc) - Koefisien rega marang bathi|4D Molecular Therapeutics (FDMT) - Pangali P/E|Rasio rega marang bathi Lexeo Therapeutics, Inc.|Kapitalisasi marang bathi Korro Bio, Inc. KRRO|Pangali P/E EDIT|Periode bali modal bisnis Silence Therapeutics Corp|Rasio rega marang bathi proqr.com PRQR|CDXS - Koefisien rega marang bathi|SGMO - Rasio rega marang bathi|Rasio kapitalisasi marang bathi resik Nautilus Biotechnology, Inc. (NAUT)|MGX: Pangali P/E|Pangali rega marang bathi DTIL|GBIO (Generation Bio) - Pangali P/E|Pangali rega marang bathi BOLD (boundlessbio.com)|Koefisien rega marang bathi XCUR (exicuretx.com)|Celsion Corporation - Pangali rega marang bathi|Pangali P/E PHIO (phiopharma.com)|Pangali P/E Mustang Bio, Inc. MBIO|RNAZ: Koefisien rega marang bathi|BNGO (Bionano Genomics) - Pangali rega marang bathi|APDN: Pangali P/E|bluebird bio (BLUE) - Pangali P/E|Rasio rega marang bathi ImmunoPrecise Antibodies Ltd.|Kapitalisasi marang bathi Omega OMGA|Pangali P/E OMIC|RGLS - Kapitalisasi marang bathi|Syros Pharmaceuticals, Inc - Koefisien rega marang bathi|Periode bali modal bisnis Codex DNA (TBIO)|TCON - Rasio rega marang bathi|UBX: Rasio rega marang bathi